Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine Pyrophosphate as Adjuvant to Metformin in Type 2 Diabetes
NCT04053621Unknown
- Sponsor
- Laboratorios Manuell
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of thiamine pyrophosphate in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Laboratorios Manuell. Primary endpoint: Hemoglobin A1c at 3 months. Status: unknown.
02
Drugs
thiamine pyrophosphate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04053621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04053621.